Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance

  1. Mannu K Walia
  2. Patricia MW Ho
  3. Scott Taylor
  4. Alvin JM Ng
  5. Ankita Gupte
  6. Alistair M Chalk
  7. Andrew CW Zannettino
  8. T John Martin
  9. Carl R Walkley  Is a corresponding author
  1. St. Vincent's Institute of Medical Research, Australia
  2. University of Adelaide, Australia

Abstract

Mutations in the P53 pathway are a hallmark of human cancer. The identification of pathways upon which p53-deficient cells depend could reveal therapeutic targets that may spare normal cells with intact p53. In contrast to P53 point mutations in other cancer, complete loss of P53 is a frequent event in osteosarcoma (OS), the most common cancer of bone. The consequences of p53 loss for osteoblastic cells and OS development are poorly understood. Here we use murine OS models to demonstrate that elevated Pthlh (Pthrp), cAMP levels and signalling via CREB1 are characteristic of both p53-deficient osteoblasts and OS. Normal osteoblasts survive depletion of both PTHrP and CREB1. In contrast, p53-deficient osteoblasts and OS depend upon continuous activation of this pathway and undergo proliferation arrest and apoptosis in the absence of PTHrP or CREB1. Our results identify the PTHrP-cAMP-CREB1 axis as an attractive pathway for therapeutic inhibition in OS.

Article and author information

Author details

  1. Mannu K Walia

    St. Vincent's Institute of Medical Research, Fitzroy, Australia
    Competing interests
    The authors declare that no competing interests exist.
  2. Patricia MW Ho

    St. Vincent's Institute of Medical Research, Fitzroy, Australia
    Competing interests
    The authors declare that no competing interests exist.
  3. Scott Taylor

    St. Vincent's Institute of Medical Research, Fitzroy, Australia
    Competing interests
    The authors declare that no competing interests exist.
  4. Alvin JM Ng

    St. Vincent's Institute of Medical Research, Fitzroy, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. Ankita Gupte

    St. Vincent's Institute of Medical Research, Fitzroy, Australia
    Competing interests
    The authors declare that no competing interests exist.
  6. Alistair M Chalk

    St. Vincent's Institute of Medical Research, Fitzroy, Australia
    Competing interests
    The authors declare that no competing interests exist.
  7. Andrew CW Zannettino

    Myeloma Research Laboratory, School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, Australia
    Competing interests
    The authors declare that no competing interests exist.
  8. T John Martin

    St. Vincent's Institute of Medical Research, Fitzroy, Australia
    Competing interests
    The authors declare that no competing interests exist.
  9. Carl R Walkley

    St. Vincent's Institute of Medical Research, Fitzroy, Australia
    For correspondence
    cwalkley@svi.edu.au
    Competing interests
    The authors declare that no competing interests exist.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Health and Medical Research Council, Australia and the Bureau of Animal Welfare, Victorian Government . All of the animals were handled according to approved institutional animal care and use committee (Animal Ethics Committee) protocols (#017/15) of the St. Vincent's Hospital Melbourne.

Human subjects: Primary human osteoblasts were isolated from bone marrow aspirates from the posterior iliac crest of de-identified healthy human adult donors with informed consent and consent to publish (IMVS/SA Pathology normal bone marrow donor program RAH#940911a, Adelaide, South Australia).

Copyright

© 2016, Walia et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,543
    views
  • 435
    downloads
  • 39
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Mannu K Walia
  2. Patricia MW Ho
  3. Scott Taylor
  4. Alvin JM Ng
  5. Ankita Gupte
  6. Alistair M Chalk
  7. Andrew CW Zannettino
  8. T John Martin
  9. Carl R Walkley
(2016)
Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance
eLife 5:e13446.
https://doi.org/10.7554/eLife.13446

Share this article

https://doi.org/10.7554/eLife.13446

Further reading

    1. Cell Biology
    2. Developmental Biology
    Filip Knop, Apolena Zounarová ... Marie Macůrková
    Research Article Updated

    During Caenorhabditis elegans development, multiple cells migrate long distances or extend processes to reach their final position and/or attain proper shape. The Wnt signalling pathway stands out as one of the major coordinators of cell migration or cell outgrowth along the anterior-posterior body axis. The outcome of Wnt signalling is fine-tuned by various mechanisms including endocytosis. In this study, we show that SEL-5, the C. elegans orthologue of mammalian AP2-associated kinase AAK1, acts together with the retromer complex as a positive regulator of EGL-20/Wnt signalling during the migration of QL neuroblast daughter cells. At the same time, SEL-5 in cooperation with the retromer complex is also required during excretory canal cell outgrowth. Importantly, SEL-5 kinase activity is not required for its role in neuronal migration or excretory cell outgrowth, and neither of these processes is dependent on DPY-23/AP2M1 phosphorylation. We further establish that the Wnt proteins CWN-1 and CWN-2, together with the Frizzled receptor CFZ-2, positively regulate excretory cell outgrowth, while LIN-44/Wnt and LIN-17/Frizzled together generate a stop signal inhibiting its extension.

    1. Cell Biology
    2. Neuroscience
    Sara Bitar, Timo Baumann ... Axel Methner
    Research Article

    Parkinson's disease (PD) is characterized by the progressive loss of dopaminergic neurons in the substantia nigra of the midbrain. Familial cases of PD are often caused by mutations of PTEN-induced kinase 1 (PINK1) and the ubiquitin ligase Parkin, both pivotal in maintaining mitochondrial quality control. CISD1, a homodimeric mitochondrial iron-sulfur-binding protein, is a major target of Parkin-mediated ubiquitination. We here discovered a heightened propensity of CISD1 to form dimers in Pink1 mutant flies and in dopaminergic neurons from PINK1 mutation patients. The dimer consists of two monomers that are covalently linked by a disulfide bridge. In this conformation CISD1 cannot coordinate the iron-sulfur cofactor. Overexpressing Cisd, the Drosophila orthologue of CISD1, and a mutant Cisd incapable of binding the iron-sulfur cluster in Drosophila reduced climbing ability and lifespan. This was more pronounced with mutant Cisd and aggravated in Pink1 mutant flies. Complete loss of Cisd, in contrast, rescued all detrimental effects of Pink1 mutation on climbing ability, wing posture, dopamine levels, lifespan, and mitochondrial ultrastructure. Our results suggest that Cisd, probably iron-depleted Cisd, operates downstream of Pink1 shedding light on PD pathophysiology and implicating CISD1 as a potential therapeutic target.